Multiple recurrent condylomata acuminata of the peni

Abstract

Condylomata acuminata of the penis are a type of anogenital venereal warts characterized by exophytic growths on the skin of the external genitalia and the mucosa of the urethra. They are caused by human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, and 35, with types 6 and 11 being the most pathogenic. The virus is primarily transmitted sexually, entering the bloodstream through mucosal or skin defects during unprotected intercourse. The presented clinical case highlights the necessity of combining surgical treatment with local and systemic pharmacotherapy in a young patient with multiple recurrent condylomata acuminata of the glans and foreskin that were resistant to conservative treatment. A combination of prolonged antiviral therapy and topical application of podophyllotoxin proved insufficient, leading to widespread penile involvement. Persistent disease progression was attributed to infection with HPV type 6. The surgical intervention included circumcision, frenuloplasty, excision of residual warts on the glans, and electrocauterization of affected skin areas, followed by antiviral therapy with interferon, which resulted in complete clinical recovery. No recurrence was observed within six months.

Keywords

condylomata acuminata / human papillomavirus / circumcision / antiviral therapy

References

[1] Bhatia N, Lynde C, Vender R, Bourcier M. Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus. J Cutan Med Surg. 2013;17(Suppl 2): S47–S54.

[2] Bhatia N., Lynde C., Vender R., Bourcier M. Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus // J Cutan Med Surg. 2013. Vol. 17 Suppl 2. P. S47–S54.

[3] Infection with human papillomavirus in penile pathologies (systematic review of the literature). Problems In Oncology. 2023;69(5):815–823. EDN: RQUOTU doi: 10.37469/0507-3758-2023-69-5-815-823

[4] Гаптулбарова К.А., Литвяков Н.В., Ибрагимова М.К. Инфицированность вирусом папилломы человека при патологиях полового члена (систематический обзор литературы) // Вопросы онкологии. 2023. Т. 69, № 5. С. 815–823. EDN: RQUOTU doi: 10.37469/0507-3758-2023-69-5-815-823

[5] O’Mahony C, Gomberg M, Skerlev M, et al. Position statement for the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol. 2019;33(6):1006–1019. EDN: ZAPIGF doi: 10.1111/jdv.15570

[6] O’Mahony C., Gomberg M., Skerlev M., et al. Position statement for the diagnosis and management of anogenital warts // J Eur Acad Dermatol Venereol. 2019. Vol. 33, N 6. P. 1006–1019. EDN: ZAPIGF doi: 10.1111/jdv.15570

[7] Ministry of Health of the Russian Federation. Anogenital (venereal) warts — Clinical recommendations. 2024. 24 p. (In Russ.)

[8] Министерство здравоохранения Российской Федерации. Аногенитальные (венерические) бородавки: клинические рекомендации. Минздрав РФ. 2024. 24 c.

[9] Gilson R, Nugent D, Werner RN, et al. 2019 IUSTI-Europe guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2020;34(8):1644–1653. doi: 10.1111/jdv.16522

[10] Gilson R., Nugent D., Werner R.N., et al. 2019 IUSTI-Europe guideline for the management of anogenital warts // J Eur Acad Dermatol Venereol. 2020. Vol. 34, N 8. P. 1644–1653. doi: 10.1111/jdv.16522

[11] Nia MH, Rahmanian F, Ghahartars M, Janghorban R. Sexual function and sexual quality of life in men with genital warts: a cross-sectional study. Reprod Health. 2022;19(1):102. doi: 10.1186/s12978-022-01403-z

[12] Nia M.H., Rahmanian F., Ghahartars M., Janghorban R. Sexual function and sexual quality of life in men with genital warts: a cross-sectional study // Reprod Health. 2022. Vol. 19, N 1. P. 102. doi: 10.1186/s12978-022-01403-z

[13] Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses. 2015;7(7):3863–3890. doi: 10.3390/v7072802

[14] Egawa N., Egawa K., Griffin H., Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of neoplasia // Viruses. 2015. Vol. 7, N 7. P. 3863–3890. doi: 10.3390/v7072802

[15] Gofur NRP, Gofur ARP, Kahdina M, et al. Ethiology and pathophysiology of whart HPV infection: a review article. Cancer Research and Cellular Therapeutics. 2022;6(1):1–4. doi: 10.31579/2640-1053/109

[16] Gofur N.R.P., Gofur A.R.P., Kahdina M., et al. Ethiology and pathophysiology of whart HPV infection: a review article // Cancer Research and Cellular Therapeutics. 2022. Vol. 6, N 1. P. 1–4. doi: 10.31579/2640-1053/109

[17] Pimenta R, Fernandes S, Noguera-Morel L, et al. Dermoscopy in pediatric dermatology — Part II: infectious and inflammatory skin lesions. Journal of the Portuguese Society of Dermatology and Venereology. 2020;78(3):197–208. doi: 10.29021/spdv.78.3.1209

[18] Pimenta R., Fernandes S., Noguera-Morel L., et al. Dermoscopy in pediatric dermatology — Part II: infectious and inflammatory skin lesions // Journal of the Portuguese Society of Dermatology and Venereology. 2020. Vol. 78, N 3. P. 197–208. doi: 10.29021/spdv.78.3.1209

[19] Pešut E, Đukić A, Lulić L, et al. Human papillomaviruses-associated cancers: an update of current knowledge. Viruses. 2021;13(11):2234. doi: 10.3390/v13112234

[20] Pešut E., Đukić A., Lulić L., et al. Human papillomaviruses-associated cancers: an update of current knowledge // Viruses. 2021. Vol. 13, N 11. P. 2234. doi: 10.3390/v13112234

[21] Pinidis P, Tsikouras P, Iatrakis G, et al. Human Papilloma Virus’ Life Cycle and Carcinogenesis [retracted in: Maedica (Bucur). 2018;13(1):85]. Maedica (Bucur). 2016;11(1):48–54.

[22] Pinidis P., Tsikouras P., Iatrakis G., et al. Human Papilloma Virus’ Life Cycle and Carcinogenesis [retracted in: Maedica (Bucur). 2018;13(1):85] // Maedica (Bucur). 2016. Vol. 11, N 1. P. 48–54.

[23] Sofiani VH, Veisi P, Rukerd MRZ, et al. The complexity of human papilloma virus in cancers: a narrative review. Infect Agent Cancer. 2023;18(1):13. doi: 10.1186/s13027-023-00488-w

[24] Sofiani V.H., Veisi P., Rukerd M.R.Z., et al. The complexity of human papilloma virus in cancers: a narrative review // Infect Agent Cancer. 2023. Vol. 18, N 1. P. 13. doi: 10.1186/s13027-023-00488-w

[25] Li S, Hong X, Wei Z, et al. Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation. Front Microbiol. 2019;10:2483. doi: 10.3389/fmicb.2019.02483

[26] Li S., Hong X., Wei Z., et al. Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation // Front Microbiol. 2019. Vol. 10. P. 2483. doi: 10.3389/fmicb.2019.02483

[27] Arnold JD, Byrne ME, Monroe AK, et al. The risk of anal carcinoma after anogenital warts in adults living with HIV. JAMA Dermatol. 2021;157(3):283–289. doi: 10.1001/jamadermatol.2020.5252

[28] Arnold J.D., Byrne M.E., Monroe A.K., et al. The risk of anal carcinoma after anogenital warts in adults living with HIV // JAMA Dermatol. 2021. Vol. 157, N 3. P. 283–289. doi: 10.1001/jamadermatol.2020.5252

[29] Prilepskaya VN, Gomberg M, Kothari S, et al. Estimating the burden of illness related to genital warts in Russia: a cross-sectional study. J Health Econ Outcomes Res. 2020;7(2):182–188. doi: 10.36469/jheor.2020.17246

[30] Prilepskaya V.N., Gomberg M., Kothari S., et al. Estimating the burden of illness related to genital warts in russia: a cross-sectional study // J Health Econ Outcomes Res. 2020. Vol. 7, N 2. P. 182–188. doi: 10.36469/jheor.2020.17246

[31] Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–702. doi: 10.15585/mmwr.mm6832a3

[32] Meites E., Szilagyi P.G., Chesson H.W., et al. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices // MMWR Morb Mortal Wkly Rep. 2019. Vol. 68, N 32. P. 698–702. doi: 10.15585/mmwr.mm6832a3

RIGHTS & PERMISSIONS

Eco-Vector